Journal of Clinical Oncology · 1985 · 83 citations · 15 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyEndocrine OncologyBreast Cancer PharmacotherapyCytotoxic ChemotherapyHormonal Cancer TherapyHormonal TherapyOncology PharmacologyPharmacodynamics Of Anticancer AgentsAntineoplastic HormonesBreast Cancer ChemotherapyBreast Cancer Endocrine TherapyBreast Cancer Hormonal TherapyBreast Cancer Hormone TherapyHormone Receptor - Positive Breast CancerHormone Receptor-positive Breast Cancer TherapyHormone Therapy Toxicity
Hormones and cytotoxic drugs are often combined in the treatment of patients with breast carcinoma to broaden the antitumor spectrum of the therapy. We found that, in vitro, the most commonly used endocrine agent, tamoxifen citrate, attenuates the cytotoxic potential of 5-fluorouracil (5-FU) and of doxorubicin. The effect was observed on estrogen receptor positive and on estrogen receptor negative breast tumor cells. Combinations of growth inhibitory hormones and cytotoxic drugs may therefore be counter-productive. For the treatment of hormone-independent tumors they may even be harmful since in these tumors tamoxifen exerts no independent cell kill that compensates for its modifying effect on the cytotoxicity of drugs.
15
A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
Herbert D. Soule, J. Vázquez, Anna Long et al. · JNCI Journal of the National Cancer Institute · 1973 · 2.5K citations
Medicine, Cell Biology, Oncology +10
Primary Bioassay of Human Myeloma Stem Cells
Anne W. Hamburger, Sydney E. Salmon · Journal of Clinical Investigation · 1977 · 467 citations · Full text